Aberrant antigen expression analyzed by flow cytometry is an marker of minimal residual disease in acute leukemia

被引:0
|
作者
Ito, S [1 ]
Ishida, Y [1 ]
Murai, K [1 ]
Kuriya, S [1 ]
机构
[1] Iwate Med Univ, Sch Med, Dept Internal Med, Div Hematol, Morioka, Iwate 020, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
379
引用
收藏
页码:786 / 786
页数:1
相关论文
共 50 条
  • [41] Comparison of two flow cytometric approaches for detection of minimal residual disease in acute leukemia patients representing aberrant antigen expression and DNA-aneuploidy simultaneously.
    Oelschlaegel, U
    Nowak, R
    Range, U
    Herbst, R
    Koeppel, C
    Schaub, A
    Ehninger, G
    BLOOD, 2000, 96 (11) : 194B - 194B
  • [42] Validation of minimal residual disease: Flow cytometry method for residual disease monitoring in Chronic Lymphocytic Leukemia
    Tangri, Shabnam
    Estrellado, Annalee
    Ranuio, Julie
    Romeo, Elisa
    Lawson, Jonny
    Feng, Lana
    Nerenberg, Mike
    Diver, Jonathan
    Harris, Sarah
    CANCER RESEARCH, 2009, 69
  • [43] Aberrant Underexpression of CD81 in Precursor B-Cell Acute Lymphoblastic Leukemia Utility in Detection of Minimal Residual Disease by Flow Cytometry
    Muzzafar, Tariq
    Medeiros, L. Jeffrey
    Wang, Sa A.
    Brahmandam, Archana
    Thomas, Deborah A.
    Jorgensen, Jeffrey L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 692 - 698
  • [44] FLOW CYTOMETRY OR IMMUNOHISTOCHEMISTRY FOR MINIMAL RESIDUAL DISEASE DETECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA?
    Hanson, Curtis
    Amador-Ortiz, Catalina
    Timm, Michael
    Morice, William
    Jevremovic, Dragan
    Shanafelt, Tait
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 : 51 - 52
  • [45] Minimal residual disease monitoring by flow cytometry
    Vidriales, MB
    San-Miguel, JF
    Orfao, A
    Coustan-Smith, E
    Campana, D
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (04) : 599 - 612
  • [46] Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic Marker
    Abaza, Hala M.
    Alfeky, Mervat A. A.
    Eissa, Deena S.
    Fattah, Mona F. Abdel
    Annaka, Laila M.
    Ebeid, Fatma S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (03) : 200 - 207
  • [47] ANEUPLOIDY AS A MARKER OF MINIMAL RESIDUAL DISEASE IN LEUKEMIA
    WALLE, AJ
    NIEDERMAYER, W
    CANCER DETECTION AND PREVENTION, 1985, 8 (1-2): : 303 - 315
  • [48] Analysis of Antigen Expression in T-Cell Acute Lymphoblastic Leukemia by Multicolor Flow Cytometry: Implications for the Detection of Measurable Residual Disease
    Semchenkova, Alexandra
    Mikhailova, Ekaterina
    Demina, Irina
    Roumiantseva, Julia
    Karachunskiy, Alexander
    Novichkova, Galina
    Popov, Alexander
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [49] Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia
    Karawajew, Leonid
    Dworzak, Michael
    Ratei, Richard
    Rhein, Peter
    Gaipa, Giuseppe
    Buldini, Barbara
    Basso, Giuseppe
    Hrusak, Ondrej
    Ludwig, Wolf-Dieter
    Henze, Guenter
    Seeger, Karl
    von Stackelberg, Arend
    Mejstrikova, Ester
    Eckert, Cornelia
    HAEMATOLOGICA, 2015, 100 (07) : 935 - 944
  • [50] Survival Analysis According to Minimal Residual Disease By Flow Cytometry in Acute Myeloid Leukemia after First Induction
    Nunez-Torron, Claudia
    Marquet Palomanes, Juan
    Martin Moro, Fernando
    Saez-Martin, Adolfo
    Luna, Alejandro
    Garcia-Garcia, Irene
    Michael Fernandez, Berta Mercedes
    Villarrubia, Jesus
    Piris-Villaespesa, Miguel
    Roldan Santiago, Ernesto
    Rodriguez Martin, Eulalia
    Moreno, Gemma
    Garcia Gutierrez, Valentin
    Lopez Jimenez, Javier
    Herrera Puente, Pilar
    BLOOD, 2019, 134